Atlas Trials

Effect of SGLT2i on Cardiovascular Biomarkers in Patients With Type 2 Diabetes and CKD Stage 3b-4

Clinical trial NCT05033054 · COMPLETED

Trial details

NCT number
NCT05033054
Sponsor
University of Texas Southwestern Medical Center
Status
COMPLETED
Study type
OBSERVATIONAL
Kidney Disease, ChronicDiabetes
Start date
2022-01-01
Primary completion
2025-01-02
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.